Application of an NGS-based 28-gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera-Reference-Cited by-同舟云学术

Application of an NGS-based 28-gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera

Published:2016-07-22 Issue:3 Volume:175 Page:419-426
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Delic Sabit¹,Rose Dominic¹,Kern Wolfgang¹,Nadarajah Niroshan¹,Haferlach Claudia¹,Haferlach Torsten¹,Meggendorfer Manja¹

Affiliation:

1. MLL Munich Leukemia Laboratory; Munich Germany

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14269/fullpdf

Reference22 articles.

1. Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias;Abdel-Wahab;Cancer Research,2010

2. Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms;Brecqueville;Genes Chromosomes. Cancer,2012

3. Therapy for myeloproliferative neoplasms: when, which agent, and how?;Geyer;Blood,2014

4. Robustness of amplicon deep sequencing underlines its utility in clinical applications;Grossmann;The Journal of Molecular Diagnostics,2013

5. The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients;Guglielmelli;Leukemia,2014

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet Factor 4 and Longevity of Patients with Essential Thromobocythemia: An Example of Antagonistic Pathogenic Pleiotropy;Rejuvenation Research;2024-06-01

2. Molecular Genetic Profile of Myelofibrosis: Implications in the Diagnosis, Prognosis, and Treatment Advancements;Cancers;2024-01-25

3. Clinical Utility and Reimbursement of Next-Generation Sequencing–Based Testing for Myeloid Malignancies;The Journal of Molecular Diagnostics;2024-01

4. Characterization of myeloproliferative neoplasms based on genetics only and prognostication of transformation to blast phase;2023-10-23

5. Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia;Journal of Hematology & Oncology;2023-08-03